Backed 3

Backed VC / United Kingdom

An early-stage frontier-technology fund focused on AI-native therapeutics, financial infrastructure and manufacturing automation. Its final close was reported at $100m on 13 Nov 2025. The mandate covers Europe and selected global markets. The stated stage focus is Pre-Seed and Seed, with emphasis on Deep Tech, Software & AI, Fintech, and Industrial Tech.

At a glance

ManagerBacked VC
Close statusFinal close
Capital$100m
Reported on13 Nov 2025
Fund typeVenture

Source and review

This fund record was manually reviewed on by the EverythingVC editorial team under our research methodology.

The capital figure reflects commitments reported by the cited source. It is not an estimate of remaining dry powder or current fundraising availability.